Purpose: Older adults experience impaired driving performance, and modify their driving habits, including limiting amount and spatial extent of travel. Alzheimer disease (AD)-related pathology, as well as spatial navigation difficulties, may influence driving performance and driving behaviors in clinically normal older adults. We examined whether AD biomarkers [cerebrospinal fluid (CSF) concentrations of Aβ 42 , tau, and ptau 181 ] were associated with lower self-reported spatial navigation abilities, and whether navigation abilities mediated the relationship of AD biomarkers with driving performance and extent.
O lder adults commonly report driving as important for maintaining autonomy. 1 However, older adults are also more likely to cease driving or reduce amount and spatial extent of everyday driving. 2 Older adults who have ceased driving exhibit declines in physical, social, and cognitive functioning compared with active older adult drivers. 3 In addition, older age is associated, with worse driving performance, and an increased risk of crashes and injuries per mile driven. 4, 5 Understanding factors contributing to altered everyday driving behaviors and lower driving performance is important for developing interventions to minimize potential negative outcomes.
Existing research, suggests impaired driving in Alzheimer disease (AD), and potentially compromised driving performance in mild cognitive impairment. 6, 7 Therefore, presence of significant AD neuropathology in clinically normal (CN) older adults (ie, preclinical AD) may also influence driving in older adults. Neurofibrillary tangles and cerebral amyloid deposition, 2 pathologic hallmarks of the disease, have been found in CN older adults at autopsy. 8 Such findings have been instrumental in elucidating presence of a preclinical stage of AD. Currently, several biomarkers exist for detecting amyloid and tau deposition antemortem. Reduced cerebrospinal fluid (CSF) levels of Aβ 42 are associated with formation of amyloid plaques. Increased CSF tau is a marker of neuronal injury and, in AD, is associated with the aggregation of hyperphosphorylated tau into neurofibrillary tangles. 9 Recent work by our group demonstrated that AD biomarkers were crosssectionally associated with errors during an on-road driving test in CN older adults. 10 In addition, baseline AD biomarker levels were found to predict longitudinal decline in driving performance, although not changes in self-reported everyday driving behaviors. 11 There is also a relatively extensive literature examining cognitive factors that may contribute to impaired driving in older adults. 12 Prior investigations have observed modest associations between driving performance and cognitive domains such as processing speed, memory, visuospatial skills, and executive functioning. 12 In addition, existing work, has demonstrated that impaired processing speed and visuospatial abilities are associated with increased likelihood of CN older adults limiting or ceasing driving. 12, 13 However, there is still a lack of consensus with regard to which cognitive domains are optimal for predicting driving performance or self-regulation of everyday driving behavior.
Spatial navigation may be particularly relevant for understanding changes in driving. Navigating an environment is a complex, multicomponential skill that allows one to travel to familiar and novel destinations. Errors in driving performance may arise due to actual or perceived need to direct more attention to finding one's way in the environment. Associations have been observed between driving performance and some component processes of spatial navigation, such as spatial planning on 2D-computerized mazes and visual attention to details in scenes potentially encountered when driving. [14] [15] [16] Difficulty with spatial orientation while driving a learned route has also been observed in older adults. 17 Furthermore, a substantial proportion of older adult drivers report difficulty navigating in unfamiliar places. 18 Finally, existing research indicates that self-reported navigation problems are associated with avoidance of unfamiliar areas 19 and restricted driving space. 20 Importantly, preclinical AD has also been associated with impaired spatial navigation abilities. 21 However, the relationships between preclinical AD, spatial navigation abilities, and driving have not been examined. Therefore, the current study examined whether preclinical AD-related difficulties in spatial navigation influence driving performance and everyday driving behaviors. We hypothesized that reduced CSF Aβ 42 and increased CSF tau would be associated with lower spatial navigation abilities. In turn, lower spatial navigation abilities would be related to lower driving performance and greater restrictions in driving extent (ie, driving exposure and driving space). Furthermore, we hypothesized that these associations would be present after controlling for other cognitive abilities previously associated with driving performance and everyday driving behaviors.
METHODS Participants
Participants (N = 112; see Tables 1 and 2) were enrolled in a longitudinal study on preclinical AD and driving performance at the Knight Alzheimer Disease Research Center at Washington University in St Louis 10,11 and screened for major medical conditions (ie, Huntington's, Parkinson's, stroke, seizure disorder, head injury). Participants were screened for dementia using the Clinical Dementia Rating Scale 22 (CDR). All participants were CN (CDR = 0), aged above 65 years, possessed a valid driver's license, and reported driving at least one time/week at baseline. Participants included are a subsample from prior reports who had all relevant data and passed screening criteria. Participants consented to participation in accordance with Washington University Human Research Protection Office guidelines.
CSF Collection and Processing
CSF was obtained by experienced neurologists through standard lumbar puncture using a 22-gauge Sprotte spinal needle to draw 20 to 30 mL of CSF at 8:00 AM following overnight fast. CSF samples were gently inverted to avoid possible gradient effects, centrifuged at low speed and frozen at −84°C after aliquoting into polypropylene tubes. All biomarker assays included a common reference standard, within-plate sample randomization and strict standardized protocol adherence. 
APOE Genotyping
APOE genotyping was collected as described previously. 23 TaqMan assays (Applied Biosystems) for both rs429358 (ABI#C_3084793_20) and rs7412 (ABI#C_904973_10) were used for APOE genotyping. Allele calling was performed using the allelic discrimination analysis module of ABI Sequence Detection Software. Positive controls for each of 6 possible APOE genotypes were also included on the genotyping plate. Samples were genotyped with the Illumina 610 or the Omniexpress chip and underwent quality control. Individuals were classified as ε4+ (44, 34, 24) or ε4− (33, 23, 22) .
Driving Test
Participants completed the 12-mile modified Washington University Road Test (mWURT), which takes about an hour to complete. 24 The course begins in a closed parking lot so that participants become familiar with the study car (ie, 4-door sedan). It proceeds to a public in-traffic route, which includes left-hand and right-hand turns, multiway intersections, and lane merges. The participant drives the mWURT as directed by an examiner in the front seat. The examiner can take control of the wheel, and the vehicle is outfitted with a second, passenger-side brake so that the examiner can apply the brake. The Record of Driving Errors (RODE) was used to obtain total number of driving errors. 24 Types of driving errors included operational (eg, signals, steering, pedals), tactical (eg, stopping, speed, yielding), or information processing (eg, attention, decision making, memory). Research indicates strong interrater reliability for total operational errors, total tactical errors, and total information-processing errors (ICC's > 0.84). 24 In terms of validity, a version of the driving test has been shown to correlate with naturalistic driving measures. 25 Two examiners scored errors over the course of this study, and were blinded to biomarker, clinical, and psychometric results. Qualitative ratings of pass, marginal and fail were also assigned, with 5 participants receiving a fail rating. The current study included all participants so as not to artificially restrict the range of error scores.
Driving Extent
Driving extent was measured using items from the Driving Habits Questionnaire 26 (DHQ), which is a 34-item self-report questionnaire to assess driving behaviors in older adults. A composite of multiple items was created to have a more robust estimate of driving extent. One set of items examined driving space, and required yes/no responses to whether the individual has driven in their neighborhood, beyond their neighborhood, to neighboring towns, to more distant towns, out of the state, and out of the region. Each item was scored as 1 or 0. The scores were summed across items and standardized using a z-transformation. The second set of items examined driving exposure, and required reporting total number of places, trips, and miles traveled during a typical week. The standardized driving extent composite was created as the average of the z-scores of the: (a) sum of yes/no items, and (b) number of places, trips, and miles traveled during a typical week. Lower scores represented more restricted driving extent.
Self-reported Navigation
The Santa Barbara Sense of Direction 27 (SBSOD), a 15-item questionnaire, was used to assess self-reported spatial navigation abilities. Participants responded on a scale of 1 (strongly agree) to 7 (strongly disagree). The 15 items were averaged to create a total score with lower scores representing lower self-rated navigation. SBSOD has demonstrated adequate reliability (Cronbach's α = 0.88) and high test-retest reliability (r = 0.91). 27 In addition, a series of experiments established the validity of the SBSOD across a variety of navigation-related tasks. SBSOD score was correlated with accuracy of identifying landmark locations in a large-scale environment, learning the layout of a new environment by actual experience, and with learning a new environment through video or virtual reality. 27 Collectively, results from these validity studies indicate that the SBSOD is strongly related to objective measures of spatial navigation skills.
Cognitive Performance
A cognitive composite was created based on measures of episodic memory, visuomotor speed, executive functioning, and visuospatial ability. Free recall from the Selective Reminding Task 28 was used to estimate episodic memory. Visuomotor speed was estimated using Trailmaking Test, part A. 29 Trailmaking Test, part B 29 served to estimate executive functioning. Finally, Block Design from the Wechsler Adult Intelligence Scale 30 (n = 95) or the Wechsler Adult Intelligence Scale-III 31 (n = 16) was used to estimate visuospatial ability. In order to have an estimate of each individual's relative ranking on Block Design for the total sample, raw scores on respective versions obtained within each subsample were standardized using a z-transformation. Scores on each individual task were standardized, and the composite score was created by averaging standardized scores. Trailmaking Test, part B data were missing for 4 individuals, and the composite score was based on data from the remaining 3 tasks.
Data Analyses
Covariates Age, sex, education, APOE status, and a health composite were control variables in analyses. Rater of the driving errors was an additional covariate in analyses of driving performance. The health composite was the sum of the presence or history of: hypertension, diabetes, depression, and heart problems (total = 0 to 4). APOE groups did not differ on any variable (Ps > 0.132), except for CSF Aβ 42 [t (110) = 4.619, P < 0.001].
Outliers
Univariate outliers were defined as values ≥ 3 SD from the mean. Analyses were conducted with and without outliers. Results were the same with outliers removed except when noted in results.
CSF Assay Drift
Recent research has observed significant drift in CSF levels over time as measured by INNOTEST. 32 This study included CSF samples collected over 3.5 years. Therefore, assay kit number was added as a covariate to determine the degree to which results were impacted by drift. Results were unchanged with assay kit number included as a covariate. Results without this variable are presented in the results.
Statistical Analyses
A mediation model was specified with an AD biomarker (ie, CSF Aβ 42 or CSF tau/ptau 181 ) as the predictor variable, self-reported navigation as mediator, and driving errors or driving extent composite as outcome variable (see Fig. 1 for hypothesized models). Both the mediator and the outcome variable were adjusted for covariates. CSF Aβ 42 and CSF tau/ ptau 181 were continuous variables. Analyses to determine total, direct, and indirect effects were conducted using the PROCESS macro 33 in SPSS 23, which implements a regression-based approach to estimate effects in conjunction with bootstrapping techniques.
The total effect represents the association of the predictor with the outcome and includes both direct and indirect effects. The direct effects indicate the degree of association between (a) the predictor variable and the mediator, (b) the mediator and the outcome variable controlling for the predictor variable, and (c) the predictor variable and the outcome variable controlling for the mediator. The indirect effect represents the degree to which the predictor variable influences the outcome variable via the mediator. Mediation analyses (ie, examination of the indirect effects) were only examined when the predictor and outcome variable were significantly related to the mediator (ie, self-reported navigation). On the basis of current recommendations, a significant relationship between the predictor variable and the outcome variable was not required. 34, 35 The significance of the indirect effect was examined using 10,000 bootstrapping samples and bias-corrected 95% confidence intervals (CIs). Significance is indicated when the CI intervals do not include 0. The cognitive composite was added as an additional covariate when an indirect effect was found to be significant to examine whether indirect effects of self-reported navigation were independent of effects of other cognitive abilities.
RESULTS

CSF Aβ 42
Both total effect and direct effects of CSF Aβ 42 were significant for driving errors (total: β = −0.226, SE = 0.085, t = −2.664, P = 0.009; direct: β = −0.243, SE = 0.087, t = −2.791, P = 0.006). Individuals with lower levels of CSF Aβ 42 made more driving errors. This is generally consistent with our prior cross-sectional finding with the larger sample. 10 There was a significant direct effect of CSF Aβ 42 on self-reported navigation (β = 0.237, SE = 0.102, t = 2.330, P = 0.022). Individuals with lower levels of CSF Aβ 42 reported lower navigational skills. Importantly, the direct effect of self-reported navigation on driving errors was not significant (β = 0.072, SE = 0.082, t = 0.881, P = 0.380). Given this lack of an association between mediator and outcome, mediation was not examined.
Results of the mediation model for driving extent are depicted in Figure 2 . Neither the total nor the direct effect of CSF Aβ 42 on the driving extent composite was significant (total: β = 0.007, SE = 0.105, t = 0.067, P = 0.947; direct: β = −0.088, SE = 0.100, t = −0.881, P = 0.381). There was a significant direct effect of CSF Aβ 42 on self-reported navigation (β = 0.240, SE = 0.100, t = 2.393, P = 0.019). In addition, the direct effect of self-reported navigation on driving extent was significant (β = 0.396, SE = 0.095, t = 4.178, P = 0.001). Individuals with lower self-reported navigation had lower scores on the driving extent composite. There was a significant indirect effect of CSF Aβ 42 on the driving extent composite through self-reported navigation (β = 0.095, SE = 0.045; 95% CI, 0.025-0.206). The indirect effect remained significant when additionally controlling for the cognitive composite (β = 0.084, SE = 0.045; 95% CI, 0.0153-0.204).
CSF tau and ptau 181
Neither the total nor the direct effect of CSF tau was significant for driving errors (total: β = 0.082, SE = 0.079, t = 1.037, P = 0.302; direct: β = 0.081, SE = 0.081, t = 1.002, P = 0.319). This is generally consistent with our prior crosssectional finding with the larger sample. 10 Similarly, neither the total nor the direct effect of CSF tau was significant for the driving extent composite (total: β = 0.123, SE = 0.094, t = 1.312, P = .192; direct: β = 0.058, SE = 0.090, t = 0.643, P = 0.522). Importantly, the direct effect of CSF tau on self-reported navigation was not significant (β = 0.179, SE = 0.091, t = 1.959, P = 0.053; with outliers removed: β = 0.138, SE = 0.108, Self-Reported Navigation FIGURE 1. Path model depicting hypothesized mediation models. The solid line from AD biomarkers to self-reported navigation represents the hypotheses that lower levels of CSF Aβ 42 and higher levels of CSF tau/ptau 181 would be associated with lower self-reported navigation. The solid line from self-reported navigation to driving reflects hypotheses that lower self-reported navigation would be associated with more driving errors and more restricted driving extent. The dashed line from AD biomarkers to driving reflects the hypotheses that self-reported spatial navigation would mediate the relationships between AD biomarkers and driving variables. AD indicates Alzheimer disease; CSF, cerebrospinal fluid. t = 1.277, P = 0.205). Results were similar for ptau 181 , as there was no association with driving errors (total: β = 0.071, SE = 0.079, t = 0.898, P = 0.371; direct: β = 0.069, SE = 0.080, t = 0.863, P = 0.390), or with the driving extent composite (total: β = 0.135, SE = 0.093, t = 1.455, P = 0.145; direct: β = 0.075, SE = 0.089, t = 0.846, P = 0.400). The direct effect of CSF ptau 181 on self-reported navigation was also not significant (β = 0.166, SE = 0.091, t = 1.825, P = 0.071; with outliers removed: β = 0.094, SE = 0.113, t = 0.829, P = 0.409). Given the lack of associations between these predictors (CSF tau and ptau 181 ) and the mediator, mediation was not examined.
DISCUSSION
The current study demonstrated that lower CSF levels of Aβ 42 (a marker of amyloid plaques in AD) were associated with lower self-reported driving extent by selfreported navigation abilities. This finding suggests that perceptions about the ability to navigate the environment may contribute to decisions about reducing driving extent for CN older adults with amyloid deposition. The lower selfreport of spatial navigation skills with increasing amyloid deposition may to some degree reflect the ability of these individuals to acquire spatial knowledge and orient within environments. That is, scores on the SBSOD scale have been associated with the ability to learn spatial layouts of largescale environments, and to update one's location during selfmotion. 27 Furthermore, a previous study observed that CN individuals with low levels of CSF Aβ 42 had greater difficulty on an objective measure of spatial navigation ability that required formation of a mental map of a novel environment. 21 In addition, some correspondence between findings based on self-reported driving space and those based on directly measuring driving area has been observed. 27 Collectively, these findings suggest that presence of amyloid plaques may impair the ability of CN individuals to effectively navigate, and that a self-report measure of spatial navigation may be useful for predicting relevant functional outcomes such as everyday driving behaviors.
The indirect effect of CSF Aβ 42 on driving extent by selfreported spatial navigation remained significant when additionally controlling for the cognitive composite. This suggests a unique mediating role for large-scale spatial navigation skills above and beyond other cognitive functions in the preclinical AD stage. In the current study, both self-reported spatial navigation and the cognitive composite (partial correlation r = 0.267, P = 0.005) were associated with aspects of everyday driving behavior in older adults, which is generally consistent with existing literature. [13] [14] [15] [16] However, there was not a significant association between CSF Aβ 42 and the cognitive composite (partial correlation r = 0.119, P = 0.224). In fact, a recent meta-analysis revealed significant, but small, associations of amyloid deposition with episodic memory and executive function, but no significant associations for working memory, processing speed or visuospatial skills. 36 Furthermore, 1 previous study observed that the ability to form a mental map of an environment, but not episodic memory, discriminated between CN individuals with and without preclinical AD. 21 These findings highlight the potential utility of particularly focusing on spatial navigation skills to understand the impact of cognitive deficits in the preclinical AD phase on relevant functional outcomes, such as everyday driving behaviors.
In contrast to CSF Aβ 42 , CSF tau and ptau 181 were not significantly related to self-reported spatial navigation ability.
This finding is similar to a prior report of a significant association between CSF Aβ 42 and the ability to form a mental map of an environment, but no such association for CSF tau. 21 The reason for the discrepancy for CSF Aβ 42 relative to CSF tau and ptau 181 is uncertain. Although CN individuals may possess both neurofibrillary tangles and amyloid plaques, 8 previous findings indicate that changes in CSF Aβ 42 may precede changes in CSF tau and, therefore, represent an earlier indicator of AD pathology in CN individuals. 37 Therefore, CSF Aβ 42 may be more related to cognitive deficits in earlier stages, whereas CSF tau and ptau 181 may be more associated with decline as the disease progresses. Consistent with this speculation, a previous study demonstrated that CSF levels of Aβ 42 , but not tau, were related to baseline measures of attention, whereas CSF levels of tau, but not Aβ 42 , were associated with longitudinal declines in attention and memory over an 8-year period. 38 Subsequent longitudinal research with a larger sample is needed to determine the relationship of each AD biomarker with changes in spatial navigation across the pathologic stages of the disease, both preclinical and symptomatic.
Notably, self-reported spatial navigation was not significantly associated with on-road driving errors, and thus could not serve as a mediator of CSF Aβ 42 effects. This suggests that perceptions of navigational skills may be relatively more predictive of self-regulation of everyday driving behaviors compared with actual driving performance in preclinical AD. However, there is a relative dearth of studies examining relationships between objective measures of navigating through large-scale environmental spaces and driving performance. Existing work only incorporates some potential component processes in a limited way, such as spatial planning in 2D-computerized mazes and visual attention to details in driving-related scenes [15] [16] [17] (but see Burns) . 18 Therefore, it is still conceivable that direct measures of specific spatial navigational skills may evidence more robust associations with actual driving problems. In addition, road tests that capture more strategic or self-directed route driving and way finding may evidence stronger associations with navigational tests.
One limitation of this study is the cross-sectional design, and longitudinal follow-up is an important next step for examining whether spatial navigation predicts reductions in driving extent over time during preclinical AD. Future work should also determine whether observed patterns differ based on APOE status. In addition, the sample size could have limited the power for detecting small, but relevant effects. As driving extent and spatial navigation abilities were both assessed using self-report measures, subjective cognitive impairment may have contributed to current findings. Although the self-report measure of spatial navigation abilities has been found to be associated with observed measures of navigation skills, 27 future research could examine spatial navigation abilities using more objective measures. A more direct measure of restricted driving space that captures day-today driving in older adults would also improve upon this study. For example, global positioning data acquisition system devices allowing measurement of variables such as driving areas, number of trips taken, and number of miles driven could more directly capture everyday driving behaviors. 39 Finally, this study did not incorporate other individual differences that may contribute to driving performance or extent such as vision, motor functioning, social network size or financial resources.
In conclusion, current findings suggest that presence of amyloid plaques as evidenced by low levels of CSF Aβ 42 is associated with lower perceived navigation in CN older adults, which limits the extent to which they drive in their environment. Future research should examine the degree to which spatial navigation skills and perceptions of such skills may influence eventual driving cessation. Future investigations should also examine ways to improve spatial navigation abilities and/or confidence in navigating in CN older adults, particularly those with amyloid plaques, so as to maintain their driving autonomy.
